Zobrazeno 1 - 10
of 170
pro vyhledávání: '"de Graeff PA"'
Publikováno v:
European Heart Journal. 37:502-509
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a06d94aa956bda6d1ab58e2403c6cf88
https://doi.org/10.1093/eurheartj/ehv685
https://doi.org/10.1093/eurheartj/ehv685
Autor:
Piening, S, Haaijer-Ruskamp, FM, de Vries, JTN, van der Elst, ME, de Graeff, PA, Straus, Sabine, Mol, PGM
Publikováno v:
Drug Safety, 35(5), 373-385. Adis
Background: After market approval, new serious safety issues are regularly identified for drugs that lead to regulatory action to inform healthcare professionals. However, the effectiveness of these safety-related regulatory actions is under question
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::04fe538ebd447df66ef758629608c78f
https://pure.eur.nl/en/publications/ba258b9a-226a-471e-9602-cbc9b7c3b619
https://pure.eur.nl/en/publications/ba258b9a-226a-471e-9602-cbc9b7c3b619
Publikováno v:
Blood Pressure, 11(2), 84-90. Taylor & Francis Group
We wondered whether, in an elderly hypertensive population in a primary prevention setting, free from diabetes mellitus and clinical atherosclerosis, differences between end organ damage and microalbuminuria (MA) could be found using a lower level of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::cd3208781afffccd8050e6c73a1406af
https://research.rug.nl/en/publications/386053ee-1d38-4698-bc4f-8bbae6933658
https://research.rug.nl/en/publications/386053ee-1d38-4698-bc4f-8bbae6933658
Publikováno v:
Pharmacy World & Science, 23(1), 28-30. Kluwer Academic Publishers
Registration files of 13 cardiovascular drugs were analysed with respect to the number of double-blind phase-III clinical trials, the use of placebo and active comparator drugs and their dosing schemes. Half of the 146 double-blind trials used active
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::7345a26242d6c65bc1c6bbf81ea01fb7
https://research.rug.nl/en/publications/ff27c10d-cfb2-4761-a121-3fa19f38c703
https://research.rug.nl/en/publications/ff27c10d-cfb2-4761-a121-3fa19f38c703
Publikováno v:
International Journal of Technology Assessment in Health Care, 17(4), 559-570. Cambridge University Press
Objectives: To study considerations used by professional and academic leaders to assess the position of new cardiovascular drugs in the therapeutic regimen in relationship to professional characteristics and the level of prescribing. Methods: Intervi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::7d02be948666ae5128c811574e0ed0ad
https://research.rug.nl/en/publications/691e880a-d19a-4192-90ad-8d86bff29e1b
https://research.rug.nl/en/publications/691e880a-d19a-4192-90ad-8d86bff29e1b
Autor:
Fijn, R, Stuurman-Bieze, AGG, van den Berg, PB, Brouwers, JRBJ, de Graeff, PA, de Jong-van den Berg, LTW
Publikováno v:
European Journal of Clinical Pharmacology, 56(9-10), 739-746. Springer Verlag
Objectives: Assessment of predictors for initiating prophylactic antithrombotic prescribing for patients newly diagnosed with ischaemic heart disease (IHD) and the impact of the introduction of national guidelines. Design and setting: A retrospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::b0dc16358b1accde288707caabb78e01
https://research.rug.nl/en/publications/bc7ae50e-557b-4d49-b595-7933538b5bff
https://research.rug.nl/en/publications/bc7ae50e-557b-4d49-b595-7933538b5bff
Publikováno v:
Drug Development Research, 51(3), 159-168
Phase III trials from registration files of cardiovascular drugs were analyzed to study the inclusion of patients with concomitant morbidity and medication. For this purpose, 15 drugs were selected which were registered in the Netherlands during the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::f9cac79d643e335ad395133800075697
https://research.rug.nl/en/publications/d0186819-95a2-4157-99c8-f5f4f65f0256
https://research.rug.nl/en/publications/d0186819-95a2-4157-99c8-f5f4f65f0256
Publikováno v:
European Journal of Clinical Pharmacology, 55(7), 537-544. Springer Verlag
Objectives: To study discrepancies in demographic characteristics between patients participating in pre-registration phase III trials of cardiovascular drugs, registered in the Netherlands, and patient populations in daily practice representing the a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::c905b030687de9639d81c8f0c3e5f138
https://research.rug.nl/en/publications/eb67df55-6109-478c-88a9-ff185a1e6f1e
https://research.rug.nl/en/publications/eb67df55-6109-478c-88a9-ff185a1e6f1e
The use of ambulatory blood pressure monitoring to evaluate antihypertensive drugs for drug approval
Autor:
de Graeff PA, Hoppe
Publikováno v:
Blood pressure monitoring. 1(3)
So far, the contribution of clinical studies using ambulatory blood pressure monitoring in the registration of a new antihypertensive agent for marketing authorization purposes has been limited. However, pre-registration studies can be particularly u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a58a2356bf275ecb7d235a699f30516e
https://pubmed.ncbi.nlm.nih.gov/10226252
https://pubmed.ncbi.nlm.nih.gov/10226252
Autor:
van den Broek, SAJ, van Veldhuisen, DJ, de Graeff, PA, CRIJNS, HJGM, VANGILST, WH, Hillege, H, Lie, KI
Publikováno v:
Journal of Heart and Lung Transplantation, 12(3), 367-371. ELSEVIER SCIENCE INC
To study whether the relative incidence of sudden death versus progressive congestive heart failure is related to the severity of congestive heart failure as assessed by determination of peak oxygen consumption, we followed 90 ambulatory patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::a606dd3fb1673da1dc417344288ff893
https://research.rug.nl/en/publications/39771b06-4a55-4bc3-bda2-723013b9a3af
https://research.rug.nl/en/publications/39771b06-4a55-4bc3-bda2-723013b9a3af